Brief: Solasia, Nippon Kayaku Announce License Agreement In Japan For New Drug Candidate Darinaparsin

Solasia Pharma KK

26/10/2021 12:54

Oct 26 (Reuters) - Nippon Kayaku Co Ltd  4272.T :
    * SOLASIA AND NIPPON KAYAKU ANNOUNCE LICENSE AGREEMENT IN
JAPAN
FOR NEW DRUG CANDIDATE DARINAPARSIN (SP-02)

Source text for Eikon:  ID:nBw7vKYL7a 
Further company coverage:  4272.T 

 ((Reuters.Briefs@thomsonreuters.com;))